Medical Cannabis News


Canadians' support for legal pot dropped in 2019; edibles interest mixed: Survey

Support for recreational cannabis among Canadians has dropped since the drug was legalized last year amid a shaky roll-out of legal pot and a still-robust black market, according to a survey published Thursday. 

In a survey conducted by Dalhousie University and the University of Guelph, half of Canadians support the legalization of recreational cannabis, down from about 69 per cent back in 2017. Meanwhile, uncertain sentiment surrounding legalization has grown to 20 per cent of the country, up from about 7 per cent two years ago, the survey found. 


Capturing Eden brings access to medical marijuana

Free for guests to enjoy, treats of brownies and cakes sat beside a brew of hemp coffee that had good reviews from visitors. A new curious customer walked in every 20 minutes or so, which was a joy for owner Stephen Barber who celebrated six months of hard work at the weekend opening of Capturing Eden.

“We recognize a need, not only in this community but throughout Canada, in especially under-serviced areas that are similar to Haliburton,” Barber said about the lack of medical marijuana access. “People are waiting long times to get medical assessments, travelling a distance to get them, and to find the right products to help their ailments. We thought this would be a good place to start.” 


Medical vs. recreational cannabis: Where should I invest?

It’s an exciting time to be a cannabis investor!

The Horizons Marijuana Life Sciences Index ETF (OTC: HMLSF) is obliterating the broader markets…

Year to date, the exchange-traded fund has more than doubled the performance of tech stocks and blue chips.

But I think its run is far from over. There are plenty of catalysts on the horizon. We have pro-cannabis legislation – like the STATES Act and the SAFE Banking Act – inching its way forward in Congress.


CBD: a marijuana miracle or just another health fad?

Aaron Horn first came across cannabidiol, or CBD, about three years ago in Glastonbury – the town, not the festival. “I found it at this amazing hemp shop, Hemp in Avalon,” recalls Horn, a musician who is now 35. “It’s run by a guy called Free. His last name is Cannabis. He changed his name by deed poll to Free Cannabis.” Horn bought a tube of high-concentration CBD paste – “it comes out like a brown toothpaste, almost” – and it was recommended he put a tiny dot on his finger and pop it in his mouth.


Cannabis company InterCure to grow medical marijuana in Canada

Israel-based medical cannabis company InterCureLtd., chaired by former Israeli Prime Minister Ehud Barak, announced in a Wednesday filing to the Tel Aviv Stock Exchange a cannabis growing agreement with an unnamed Canadian company.

Under the agreement, the two will form a new company that will grow medical cannabis in an indoor facility in Canada.

InterCure subsidiary Canndoc will own 51% of the new company and contribute its cannabis growing experience, while the Canadian company will hold 49% and invest the resources needed to set up the facility and distribute the output.

In an interview with Calcalist, Canndoc CEO Roei Zerahia said the agreement will enable the company to quickly achieve sales in the Canadian market, without relying on export from Israel.


We were right about the year of CBD stocks – and there’s still time to profit

2019 is shaping up to be the most profitable year yet for CBD – the medicinal compound derived from marijuana. And there's still time to make a huge profit on what's quickly becoming a billion-dollar industry.

The Hemp Business Journal reports that the CBD industry, worth only $170 million in 2017, could be worth $1.1 billion by the end of next year.

And that figure could balloon to even greater heights in just the next three years. According to the Brightfield Group, the CBD industry could be worth as much as $22 billion by 2022.

That 12,000% growth potential is simply unheard of. That's why we've been telling our readers all about CBD.


'At first we all thought are there skunks around here,' neighbours fed up with medical marijuana grow-op

People living on a quiet street in The Maples say they're tired of sharing the neighbourhood with a medical marijuana grow-op.

The house was purchased by a couple two years ago, according to land title documents, but neighbours say no one ever moved in. The owners live in another home on the same street and have only used this house to grow medical marijuana plants.

"They bought this house for a grow-op I guess," neighbour Rogelio Laoag told CBC News.

Laoag and his wife have lived in their home for about 20 years but since their neighbours' home turned into a grow-op in 2017, they haven't been able to enjoy their backyard. They say the smell of cannabis is so strong it makes them feel light-headed.


Shoppers Drug Mart adds HelloMD’s on-demand advice to online cannabis sales

In its biggest Canadian deal to date, HelloMD is now providing health practitioner advice through the Shoppers Drug Mart medical cannabis website to streamline access for patients.

“We worked tremendously hard to be awarded this business, and being selected by Shoppers is that crowning jewel that we’ve been building towards,” says Larry Lisser, senior vice-president of business development at HelloMD.

The Medical Cannabis by Shoppers website was already up and running in Ontario and Alberta, but now it features a dedicated consultation portal operated by HelloMD.


Winnipeg councillor looking to limit amount of medical pot grown in homes

A Winnipeg city councillor says it's time to move large scale medical marijuana grow ops out of residential neighbourhoods and into industrial areas.

Health Canada says people with a registered certificate to grow medical pot in their homes for personal use can possess up to 150 dried grams or 300 fresh grams.

There can also be up to four registrations in place for production at one location.

Coun. Ross Eadie says he's been receiving complaints about suspected medical grow ops causing odour and noise problems in two neighbourhoods. 

“A person’s right to medical cannabis does not trump people’s right to live comfortably next door,” says Eadie


Zenabis partners with Farmako to supply mass produced CBD isolate in Canada and medical cannabis to Germany

Zenabis Global Inc. (TSXV: ZENA)("Zenabis" or the "Company") is pleased to announce that it has entered into a binding term sheet for a three-year supply arrangement with leading German pharmaceutical research company Farmako GmbH ("Farmako") for: (1) the supply of biosynthetically produced pure CBD isolate oil (99.9%) from Farmako to Zenabis for sale in Canada; and (2) the supply of European Union Good Manufacturing Practices ("EU GMP") certified cannabis cultivated in Zenabis' indoor facilities in Canada for sale by Farmako to the German medical market.


Subscribe to RSS - Medical Cannabis News